Related references
Note: Only part of the references are listed.Human leukocyte antigens HLA DRB1 influence clinical outcome of chronic lymphocytic leukemia
Ewa Lech-Maranda et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2007)
Long-term idiotype vaccination combined with interleukin-12 (IL-12), or IL-12 and granulocyte macrophage colony-stimulating factor, in early-stage multiple myeloma patients
Lotta Hansson et al.
CLINICAL CANCER RESEARCH (2007)
Prognostic and biological implications of genetic abnormalities in multiple myeloma undergoing autologous stem cell transplantation: t(4;14) is the most relevant adverse prognostic factor, whereas RB deletion as a unique abnormality is not associated with adverse prognosis
N. C. Gutierrez et al.
LEUKEMIA (2007)
Human leucocyte antigen-C in B chronic lymphocytic leukaemia
Olga Montes-Ares et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Prevalence of HLA-DRB1 genotype and altered Fas/Fas ligand expression in adrenocortical carcinoma
GW Wolkersdörfer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
HLA allele frequency and clinical outcome in Italian patients with cutaneous melanoma
V Luongo et al.
TISSUE ANTIGENS (2004)
Impact of CD34+ cell dose on the outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation
JA Pérez-Simón et al.
BLOOD (2003)
Idiotype vaccination in multiple myeloma induced a reduction of circulating clonal tumor B cells
T Rasmussen et al.
BLOOD (2003)
Chronic but not acute graft-versus-host disease improves outcome in multiple myeloma patients after non-myeloablative allogeneic transplantation
JA Pérez-Simón et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
HLA class I and class II antigens associated with multiple myeloma in southern Africa
M Patel et al.
CLINICAL AND LABORATORY HAEMATOLOGY (2002)
T-cell expansions in patients with multiple myeloma have a phenotype of cytotoxic T cells
M Raitakari et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Infusion of lymphocytes obtained from a donor immunised with the paraprotein idiotype as a treatment in a relapsed myeloma
R Cabrera et al.
BONE MARROW TRANSPLANTATION (2000)
Share Paper
